These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 9002958)
1. A cysteine protease inhibitor prevents activation-induced T-cell apoptosis and death of peripheral blood cells from human immunodeficiency virus-infected individuals by inhibiting upregulation of Fas ligand. Yang Y; Liu ZH; Ware CF; Ashwell JD Blood; 1997 Jan; 89(2):550-7. PubMed ID: 9002958 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. Badley AD; McElhinny JA; Leibson PJ; Lynch DH; Alderson MR; Paya CV J Virol; 1996 Jan; 70(1):199-206. PubMed ID: 8523526 [TBL] [Abstract][Full Text] [Related]
3. HIV-induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas-Fas ligand. Noraz N; Gozlan J; Corbeil J; Brunner T; Spector SA AIDS; 1997 Nov; 11(14):1671-80. PubMed ID: 9386801 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of Fas expression in the lymph nodes of patients infected with human immunodeficiency virus. Wang L; Adegboyega PA Arch Pathol Lab Med; 2002 Jan; 126(1):28-32. PubMed ID: 11800643 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. Katsikis PD; Garcia-Ojeda ME; Torres-Roca JF; Tijoe IM; Smith CA; Herzenberg LA; Herzenberg LA J Exp Med; 1997 Oct; 186(8):1365-72. PubMed ID: 9334376 [TBL] [Abstract][Full Text] [Related]
6. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice. Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021 [TBL] [Abstract][Full Text] [Related]
7. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Estaquier J; Tanaka M; Suda T; Nagata S; Golstein P; Ameisen JC Blood; 1996 Jun; 87(12):4959-66. PubMed ID: 8652808 [TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo. Sloand EM; Kumar PN; Kim S; Chaudhuri A; Weichold FF; Young NS Blood; 1999 Aug; 94(3):1021-7. PubMed ID: 10419894 [TBL] [Abstract][Full Text] [Related]
10. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681 [TBL] [Abstract][Full Text] [Related]
11. Upregulated expression of Fas and Fas ligand in brain through the spectrum of HIV-1 infection. Elovaara I; Sabri F; Gray F; Alafuzoff I; Chiodi F Acta Neuropathol; 1999 Oct; 98(4):355-62. PubMed ID: 10502040 [TBL] [Abstract][Full Text] [Related]
12. Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons. Hosaka N; Oyaizu N; Kaplan MH; Yagita H; Pahwa S J Infect Dis; 1998 Oct; 178(4):1030-9. PubMed ID: 9806031 [TBL] [Abstract][Full Text] [Related]
13. Fas/FasL interaction is not involved in apoptosis of activated CD4+ T cells upon HIV-1 infection in vitro. Yagi T; Sugimoto A; Tanaka M; Nagata S; Yasuda S; Yagita H; Kuriyama T; Takemori T; Tsunetsugu-Yokota Y J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):307-15. PubMed ID: 9704935 [TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitors block Ras/ERK signaling pathway resulting in the downregulation of Fas ligand expression during activation-induced cell death in T cells. Tanimoto Y; Kizaki H J Biochem; 2002 Mar; 131(3):319-26. PubMed ID: 11872160 [TBL] [Abstract][Full Text] [Related]
15. HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Mitra D; Steiner M; Lynch DH; Staiano-Coico L; Laurence J Immunology; 1996 Apr; 87(4):581-5. PubMed ID: 8675212 [TBL] [Abstract][Full Text] [Related]
16. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression. Kaser A; Nagata S; Tilg H Cytokine; 1999 Oct; 11(10):736-43. PubMed ID: 10525311 [TBL] [Abstract][Full Text] [Related]
17. Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. Sloand EM; Young NS; Kumar P; Weichold FF; Sato T; Maciejewski JP Blood; 1997 Feb; 89(4):1357-63. PubMed ID: 9028959 [TBL] [Abstract][Full Text] [Related]
18. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. Yang Y; Merćep M; Ware CF; Ashwell JD J Exp Med; 1995 May; 181(5):1673-82. PubMed ID: 7536793 [TBL] [Abstract][Full Text] [Related]
19. CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells. Algeciras-Schimnich A; Vlahakis SR; Villasis-Keever A; Gomez T; Heppelmann CJ; Bou G; Paya CV AIDS; 2002 Jul; 16(11):1467-78. PubMed ID: 12131184 [TBL] [Abstract][Full Text] [Related]
20. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease. Silvestris F; Cafforio P; Tucci M; Del Prete A; Dammacco F Mol Med; 2000 Jun; 6(6):509-26. PubMed ID: 10972087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]